BR9913791A - Combinação, formulação farmacêutica, método para o tratamento de um mamìfero, incluindo um humano, com uma infecção por hbv, uso de uma combinação, e, embalagem para pacientes - Google Patents
Combinação, formulação farmacêutica, método para o tratamento de um mamìfero, incluindo um humano, com uma infecção por hbv, uso de uma combinação, e, embalagem para pacientesInfo
- Publication number
- BR9913791A BR9913791A BR9913791-7A BR9913791A BR9913791A BR 9913791 A BR9913791 A BR 9913791A BR 9913791 A BR9913791 A BR 9913791A BR 9913791 A BR9913791 A BR 9913791A
- Authority
- BR
- Brazil
- Prior art keywords
- combination
- patients
- packaging
- treating
- human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"COMBINAçãO, FORMULAçãO FARMACêUTICA, MéTODO PARA O TRATAMENTO DE UM MAMìFERO, INCLUINDO UM HUMANO, COM UMA INFECçãO POR HBV, USO DE UMA COMBINAçãO, E, EMBALAGEM PARA PACIENTES". A presente invenção refere-se a combinações terapêuticas compreendendo (2R,cis)-4-amino-1-(2-hidroximetil-1,3-oxatiolan-5-il)-pirimidin-2-ona (lamivudina) e um segundo agente terapêutico selecionado dentre (9-[(R)-2-(fosfonometoxi) etil] adenina, (PMEA ou adefovir) e bis(pivaloiloximetil) (9-[(R)-2-(fosfonometoxi) etil] adenina, (a prodroga oral de PMEA, adefovir dipivoxil) que tem atividade anti-vírus de hepatite B. A presente invenção também se refere a composições farmacêuticas contendo referidas combinações e seu uso no tratamento de infecções por HBV incluindo infecções com mutantes de HBV contendo resistência a inibidores de nucleosídeo e/ou não nucleosídeo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9820420.9A GB9820420D0 (en) | 1998-09-18 | 1998-09-18 | Antiviral combinations |
PCT/EP1999/006886 WO2000016755A2 (en) | 1998-09-18 | 1999-09-17 | Antiviral combinations of lamivudine and adefovir |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9913791A true BR9913791A (pt) | 2001-05-29 |
Family
ID=10839133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9913791-7A BR9913791A (pt) | 1998-09-18 | 1999-09-17 | Combinação, formulação farmacêutica, método para o tratamento de um mamìfero, incluindo um humano, com uma infecção por hbv, uso de uma combinação, e, embalagem para pacientes |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1113802B1 (pt) |
JP (1) | JP2002526441A (pt) |
KR (1) | KR100413312B1 (pt) |
CN (1) | CN1178660C (pt) |
AR (1) | AR023661A1 (pt) |
AT (1) | ATE270106T1 (pt) |
AU (1) | AU755633B2 (pt) |
BR (1) | BR9913791A (pt) |
CA (1) | CA2344172A1 (pt) |
CZ (1) | CZ2001977A3 (pt) |
DE (1) | DE69918447T2 (pt) |
ES (1) | ES2223183T3 (pt) |
GB (1) | GB9820420D0 (pt) |
HK (1) | HK1035670A1 (pt) |
HU (1) | HU227677B1 (pt) |
IL (1) | IL141844A0 (pt) |
NO (1) | NO20011358L (pt) |
NZ (1) | NZ510380A (pt) |
PL (1) | PL358988A1 (pt) |
TR (1) | TR200101486T2 (pt) |
TW (1) | TW555559B (pt) |
WO (1) | WO2000016755A2 (pt) |
ZA (1) | ZA200101920B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA986614B (en) | 1997-07-25 | 1999-01-27 | Gilead Sciences | Nucleotide analog composition |
HU230698B1 (hu) | 2000-02-29 | 2017-09-28 | Bristol-Myers Squibb Holdings Ireland | Alacsony dózisú entecavir formuláció és alkalmazása |
CN1303089C (zh) * | 2002-11-19 | 2007-03-07 | 天津药物研究院 | 阿德福韦酯结晶形态及其制备方法 |
US20040224917A1 (en) | 2003-01-14 | 2004-11-11 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
UA93354C2 (ru) * | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Местный противовирусный препарат |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
AU2006325404B2 (en) * | 2005-12-14 | 2012-03-01 | Cipla Limited | Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
EP2519243B1 (en) * | 2009-12-31 | 2015-04-22 | Zhou, Xiao-Jian | Compositions and methods for treating hepatitis b virus infection |
WO2012062835A1 (en) * | 2010-11-12 | 2012-05-18 | Glaxo Wellcome Manufacturing Pte Ltd | Novel pharmaceutical compositions |
CN113880898B (zh) * | 2020-10-30 | 2023-07-25 | 杭州拉林智能科技有限公司 | 黄酮苷-有机胺类抗微生物剂复盐化合物及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999066936A1 (en) * | 1998-06-24 | 1999-12-29 | Emory University | Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
-
1998
- 1998-09-18 GB GBGB9820420.9A patent/GB9820420D0/en not_active Ceased
-
1999
- 1999-09-16 AR ARP990104660A patent/AR023661A1/es not_active Application Discontinuation
- 1999-09-17 CA CA002344172A patent/CA2344172A1/en not_active Abandoned
- 1999-09-17 CN CNB998132683A patent/CN1178660C/zh not_active Expired - Fee Related
- 1999-09-17 NZ NZ510380A patent/NZ510380A/en not_active IP Right Cessation
- 1999-09-17 DE DE69918447T patent/DE69918447T2/de not_active Expired - Lifetime
- 1999-09-17 BR BR9913791-7A patent/BR9913791A/pt not_active Application Discontinuation
- 1999-09-17 AT AT99947376T patent/ATE270106T1/de not_active IP Right Cessation
- 1999-09-17 EP EP99947376A patent/EP1113802B1/en not_active Expired - Lifetime
- 1999-09-17 TR TR2001/01486T patent/TR200101486T2/xx unknown
- 1999-09-17 HU HU0103858A patent/HU227677B1/hu not_active IP Right Cessation
- 1999-09-17 JP JP2000573716A patent/JP2002526441A/ja active Pending
- 1999-09-17 PL PL99358988A patent/PL358988A1/xx unknown
- 1999-09-17 ES ES99947376T patent/ES2223183T3/es not_active Expired - Lifetime
- 1999-09-17 KR KR10-2001-7003481A patent/KR100413312B1/ko not_active IP Right Cessation
- 1999-09-17 CZ CZ2001977A patent/CZ2001977A3/cs unknown
- 1999-09-17 AU AU60851/99A patent/AU755633B2/en not_active Ceased
- 1999-09-17 IL IL14184499A patent/IL141844A0/xx unknown
- 1999-09-17 WO PCT/EP1999/006886 patent/WO2000016755A2/en active IP Right Grant
- 1999-10-11 TW TW088117512A patent/TW555559B/zh not_active IP Right Cessation
-
2001
- 2001-03-07 ZA ZA200101920A patent/ZA200101920B/en unknown
- 2001-03-16 NO NO20011358A patent/NO20011358L/no not_active Application Discontinuation
- 2001-09-07 HK HK01106346A patent/HK1035670A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU6085199A (en) | 2000-04-10 |
JP2002526441A (ja) | 2002-08-20 |
IL141844A0 (en) | 2002-03-10 |
CN1178660C (zh) | 2004-12-08 |
KR20010075192A (ko) | 2001-08-09 |
AU755633B2 (en) | 2002-12-19 |
KR100413312B1 (ko) | 2004-01-03 |
HK1035670A1 (pt) | 2001-12-07 |
TR200101486T2 (tr) | 2001-12-21 |
ZA200101920B (en) | 2002-03-07 |
DE69918447T2 (de) | 2005-08-04 |
CA2344172A1 (en) | 2000-03-30 |
HUP0103858A2 (hu) | 2002-05-29 |
NO20011358L (no) | 2001-04-17 |
PL358988A1 (en) | 2004-08-23 |
TW555559B (en) | 2003-10-01 |
HUP0103858A3 (en) | 2004-03-01 |
WO2000016755A3 (en) | 2000-05-25 |
GB9820420D0 (en) | 1998-11-11 |
NZ510380A (en) | 2003-07-25 |
DE69918447D1 (de) | 2004-08-05 |
EP1113802A2 (en) | 2001-07-11 |
ATE270106T1 (de) | 2004-07-15 |
ES2223183T3 (es) | 2005-02-16 |
NO20011358D0 (no) | 2001-03-16 |
WO2000016755A2 (en) | 2000-03-30 |
EP1113802B1 (en) | 2004-06-30 |
CN1326349A (zh) | 2001-12-12 |
CZ2001977A3 (cs) | 2001-08-15 |
AR023661A1 (es) | 2002-09-04 |
HU227677B1 (en) | 2011-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI9607851B8 (pt) | combinação e formulação farmacêutica. | |
PL408254A1 (pl) | Kompozycje i i sposoby wykorzystywane w skojarzonej terapii przeciwwirusowej | |
RS20120201A3 (en) | METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C | |
AR035711A1 (es) | Prodrogas 3' de 2'-desoxi-beta-l-nucleosidos; sus composiciones farmaceuticas; metodo para el tratamiento o profilaxis de una infeccion del virus de la hepatitis b y sus usos para la manufactura de composiciones farmaceuticas | |
BR0312286A (pt) | pró-medicamentos de 2' e 3' - nucleosìdeo modificado para tratamento de infecções por flaviviridae | |
NL300286I2 (nl) | Beta-L-2'-desoxynucleosiden voor de behandeling van Heparitis-B-virus. | |
JP2004513070A5 (pt) | ||
CZ283765B6 (cs) | 1,3-Oxathiolannukleosidové analogy | |
HUP0301112A2 (hu) | Eljárás flavivirus-fertőzések kezelésére és megelőzésére nukleozid-analógokkal | |
BR9913791A (pt) | Combinação, formulação farmacêutica, método para o tratamento de um mamìfero, incluindo um humano, com uma infecção por hbv, uso de uma combinação, e, embalagem para pacientes | |
CA2622879A1 (en) | Use of a3 adenosine receptor agonist in osteoarthritis treatment | |
BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
ES2314157T3 (es) | Terapia de combinacion para tratar el virus de la hepatitis b. | |
AR026255A1 (es) | Combinaciones antivirales. | |
NZ601519A (en) | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION comprising lamivudine and adefovir dipivoxil | |
AR101679A2 (es) | Composiciones para el tratamiento antiviral combinado | |
SE0102309D0 (sv) | Farmaceutisk engång-om-dagen-komposition innehållande brivudin | |
AR013424A1 (es) | Uso de uridina para la preparacion de una composicion farmaceutica util para inhibir la toxicidad de los analogos de pirimidina | |
CY1117836T1 (el) | Βητα-l-2'-δεοξυ-νουκλεοσιδια για την θεραπεια ηπατιτιδας β | |
CA2538205A1 (en) | Nucleosides with anti-hepatitis b virus activity | |
TH84854A (th) | สารรวมต้านไวรัส | |
TH62931B (th) | สารรวมต้านไวรัส |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |